SciClone Pharmaceuticals, Inc. to Present at Biotechnology Industry Organization (BIO) CEO and Investor Conference

FOSTER CITY, CA--(Marketwire - February 05, 2008) - SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that Friedhelm Blobel, Ph.D., President and Chief Executive Officer, will present a corporate overview at the BIO CEO and Investor Conference 2008 on February 12, 2008 at 4:15 p.m. ET in New York City. In addition, Israel Rios, M.D., Chief Medical Officer, will participate in the panel presentation “HCV: Beyond the Coin Toss SVRs” on February 11, 2008 from 9:30 a.m. to 11:00 a.m. ET. To access the live audio webcast of the corporate presentation, log on through a link located in the Investor Relations section of SciClone’s website at www.sciclone.com. A replay of the webcast will be available until March 14, 2008.

MORE ON THIS TOPIC